tirzepatide heart How the weight loss drug is also helping failure patients ESC 2025: study supports use

Rotate injection sites to avoid lipodystrophy

Both ligands had similar cAMP potency but the exendin-4-C16 showed 2.5-fold bias towards G protein recruitment and a 60% reduction in -arrestin-2 recruitment efficacy compared to exendin-4, as well as reduced GLP-1R endocytosis and preferential targeting towards recycling pathways

In some cases, Ozempic can cause changes in taste, also known as dysgeusia

Since there is widespread use of these medications, it is important for people to be aware of all potential side effects and complications

Ozempic produces less weight loss on average than dedicated weight loss medications because its dosing is calibrated for diabetes management rather than weight reduction

These results are consistent with SURPASS2, a 40week, openlabel, phase 3 trial in a cohort of patients with metformintreated T2D in which onceweekly tirzepatide (5, 10, or 15 mg) was noninferior and superior to semaglutide 1 mg for HbA1c reduction and produced substantially greater, dosedependent weight loss